Patents by Inventor Philip A Carpino

Philip A Carpino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-thiopyrimidinones
    Patent number: 9873673
    Abstract: Myeloperoxidase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, cardiovascular conditions.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: January 23, 2018
    Assignee: Pfizer Inc.
    Inventors: Philip A. Carpino, Edward L. Conn, Robert L. Dow, Matthew S. Dowling, David Hepworth, Daniel Wei-Shung Kung, Suvi Orr, Benjamin N. Rocke, Roger B. Ruggeri, Matthew F. Sammons, Joseph S. Warmus, Yan Zhang
  • 2-Thiopyrimidinones
    Publication number: 20160304469
    Abstract: Myeloperoxidase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, cardiovascular conditions.
    Type: Application
    Filed: June 24, 2016
    Publication date: October 20, 2016
    Applicant: Pfizer Inc.
    Inventors: Philip A. Carpino, Edward L. Conn, Robert L. Dow, Matthew S. Dowling, David Hepworth, Daniel Wei-Shung Kung, Suvi Orr, Benjamin N. Rocke, Roger B. Ruggeri, Matthew F. Sammons, Joseph S. Warmus, Yan Zhang
  • 2-thiopyrimidinones
    Patent number: 9399626
    Abstract: Myeloperoxidase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, cardiovascular conditions.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: July 26, 2016
    Assignee: Pfizer Inc.
    Inventors: Philip A. Carpino, Edward L. Conn, Robert L. Dow, Matthew S. Dowling, David Hepworth, Daniel Wei-Shung Kung, Suvi Orr, Benjamin N. Rocke, Roger B. Ruggeri, Matthew F. Sammons, Joseph S. Warmus, Yan Zhang
  • Diacylglycerol acyltransferase 2 inhibitors
    Patent number: 9296745
    Abstract: Derivatives of purine, 3H-imidazo[4,5-b]pyrimidine and 1H-imidazo[4,5-d]pyrazine of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: March 29, 2016
    Assignee: Pfizer Inc.
    Inventors: Kay Ahn, Markus Boehm, Shawn Cabral, Philip A. Carpino, Kentaro Futatsugi, David Hepworth, Daniel W. Kung, Suvi Orr, Jian Wang
  • DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS
    Publication number: 20150087585
    Abstract: Derivatives of purine, 3H-imidazo[4,5-b]pyrimidine and 1H-imidazo[4,5-d]pyrazine of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
    Type: Application
    Filed: March 26, 2013
    Publication date: March 26, 2015
    Applicant: PFIZER INC.
    Inventors: Kay Ahn, Markus Boehm, Shawn Cabral, Philip A. Carpino, Kentaro Futatsugi, David Hepworth, Daniel W. Kung, Suvi Orr, Jian Wang
  • 2-Thiopyrimidinones
    Publication number: 20140288049
    Abstract: Myeloperoxidase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, cardiovascular conditions.
    Type: Application
    Filed: June 9, 2014
    Publication date: September 25, 2014
    Inventors: Philip A. Carpino, Edward L. Conn, Robert L. Dow, Matthew S. Dowling, David Hepworth, Daniel Wei-Shung Kung, Suvi Orr, Benjamin N. Rocke, Roger B. Ruggeri, Matthew F. Sammons, Joseph S. Warmus, Yan Zhang
  • 2-Thiopyrimidinones
    Publication number: 20130123230
    Abstract: Myeloperoxidase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, cardiovascular conditions.
    Type: Application
    Filed: November 7, 2012
    Publication date: May 16, 2013
    Inventors: Philip A. Carpino, Edward L. Conn, Robert L. Dow, Matthew S. Dowling, David Hepworth, Daniel Wei-Shung Kung, Suvi Orr, Benjamin N. Rocke, Roger B. Ruggeri, Matthew F. Sammons, Joseph S. Warmus, Yan Zhang
  • Cannabinoid receptor ligands and uses thereof
    Patent number: 7354929
    Abstract: Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: April 8, 2008
    Assignee: Pfizer Inc.
    Inventors: Philip A. Carpino, David A. Griffith
  • CANNABINOID RECEPTOR LIGANDS AND USES THEREOF
    Publication number: 20070213334
    Abstract: Compounds of Formula (I) or (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
    Type: Application
    Filed: May 11, 2007
    Publication date: September 13, 2007
    Inventors: Philip Carpino, Subas Sakya
  • Cannabinoid receptor ligands and uses thereof
    Patent number: 7241788
    Abstract: Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein
    Type: Grant
    Filed: May 12, 2006
    Date of Patent: July 10, 2007
    Assignee: Pfizer Inc.
    Inventors: Philip A. Carpino, Robert L. Dow
  • Cannabinoid receptor ligands and uses thereof
    Patent number: 7232823
    Abstract: Compounds of Formula (I) or (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein
    Type: Grant
    Filed: May 25, 2004
    Date of Patent: June 19, 2007
    Assignee: Pfizer, Inc.
    Inventors: Philip A. Carpino, Subas M. Sakya
  • Cannabinoid receptor ligands and uses thereof
    Patent number: 7230024
    Abstract: Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
    Type: Grant
    Filed: May 12, 2006
    Date of Patent: June 12, 2007
    Assignee: Pfizer Inc
    Inventors: Philip A. Carpino, Robert L. Dow
  • CANNABINOID RECEPTOR LIGANDS AND USES THEREOF
    Publication number: 20070105856
    Abstract: Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
    Type: Application
    Filed: October 4, 2006
    Publication date: May 10, 2007
    Inventors: Philip Carpino, David Griffith
  • BICYCLIC PYRAZOLYL AND IMIDAZOLYL COMPOUNDS AND USES THEREOF
    Publication number: 20070027133
    Abstract: Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.
    Type: Application
    Filed: September 7, 2006
    Publication date: February 1, 2007
    Inventors: Philip Carpino, Robert Dow, David Griffith
  • Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
    Patent number: 7151097
    Abstract: Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: December 19, 2006
    Assignee: Pfizer Inc.
    Inventors: Philip A. Carpino, Robert L. Dow, David A. Griffith
  • Cannabinoid receptor ligands and uses thereof
    Patent number: 7145012
    Abstract: Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein
    Type: Grant
    Filed: April 12, 2004
    Date of Patent: December 5, 2006
    Assignee: Pfizer Inc.
    Inventors: Philip A. Carpino, Robert L. Dow
  • Cannabiniod receptor ligands and uses thereof
    Patent number: 7141669
    Abstract: Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein
    Type: Grant
    Filed: April 12, 2004
    Date of Patent: November 28, 2006
    Assignee: Pfizer Inc.
    Inventors: Philip A. Carpino, David A. Griffith
  • Acylaminobicyclic heteroaromatic compounds and uses thereof
    Publication number: 20060241100
    Abstract: Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.
    Type: Application
    Filed: April 20, 2006
    Publication date: October 26, 2006
    Inventors: Robert Dow, Philip Carpino
  • Cannabinoid receptor ligands and uses thereof
    Publication number: 20060205720
    Abstract: Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
    Type: Application
    Filed: May 12, 2006
    Publication date: September 14, 2006
    Inventors: Philip Carpino, Robert Dow
  • Cannabinoid receptor ligands and uses thereof
    Publication number: 20060205948
    Abstract: Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
    Type: Application
    Filed: May 12, 2006
    Publication date: September 14, 2006
    Inventors: Philip Carpino, Robert Dow